Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "Bio"
Home
FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients
CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a laboratory to attack cancer cells, and...
10/20/2026, 09:25 ET
Asan Medical Center Introduces Korea’s First Transperineal Robotic Prostate Biopsy System
In prostate cancer diagnostics, minimizing procedural infection risks is as vital as accurately sampling suspicious tissue.
10/19/2026, 04:07 ET
Beyond Facial Wrinkles: 5 Internal Factors Accelerating Biological Aging
Aging is an inevitable biological process, but the rate at which it occurs is largely within individual control.
10/07/2026, 03:25 ET
MS Bio Pursues IPO to Fuel Expansion into Amniotic Lenses, Aesthetics, and Global Markets
MS Bio, a specialized manufacturer of human tissue graft materials and medical devices, is leveraging its upcoming...
10/06/2026, 03:25 ET
Pediatric Crohn’s: Switching Biologics Yields Similar Remission Rates Despite Lower Blood Drug Levels
Pediatric and adolescent Crohn’s disease patients who switch to infliximab after losing responsiveness to adalimumab...
10/06/2026, 03:24 ET
Samsung Biologics Slashes Biopharma Development Timeline to 9.5 Months at BioProcess International 2026
Samsung Biologics has unveiled a process innovation case study demonstrating a reduction in biopharmaceutical...
10/06/2026, 03:23 ET
‘Singapore Is the Bridge, Not the Destination’: Novo Holdings Connects Asian Biotech to Global Capital
Global life sciences investment firm Novo Holdings is bringing its proven European biotech company-building playbook to...
09/21/2026, 22:03 ET
Samsung Biologics to Raise ₩3 Trillion in Rights Offering to Fund ₩2.7 Trillion Acquisition of PolyPeptide Group
Samsung Biologics is proceeding with a 3 trillion won ($2.25 billion) rights offering, directing approximately 90% of...
09/21/2026, 02:06 ET
Turning Off Cancer Signals: New Precision Drug Stops Tumors Without Harming Healthy Cells
South Korean researchers have developed a novel anticancer approach capable of selectively turning off specific...
09/13/2026, 10:34 ET
Celltrion to Select Japanese Biotech Startups for Joint R&D and Pipeline Expansion
Celltrion is stepping up efforts to identify and foster promising biotech startups in Japan.
09/13/2026, 10:33 ET
1
2
3
Next